Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
68.82
+3.26 (4.97%)
At close: Jan 23, 2026
BOM:524412 Revenue
Aarey Drugs & Pharmaceuticals had revenue of 841.62M INR in the quarter ending September 30, 2025, a decrease of -19.96%. This brings the company's revenue in the last twelve months to 4.28B, down -18.56% year-over-year. In the fiscal year ending March 31, 2025, Aarey Drugs & Pharmaceuticals had annual revenue of 4.74B with 17.73% growth.
Revenue (ttm)
4.28B
Revenue Growth
-18.56%
P/S Ratio
0.45
Revenue / Employee
32.44M
Employees
132
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.74B | 713.61M | 17.73% |
| Mar 31, 2024 | 4.03B | -163.73M | -3.91% |
| Mar 31, 2023 | 4.19B | -739.78M | -15.01% |
| Mar 31, 2022 | 4.93B | 1.42B | 40.27% |
| Mar 31, 2021 | 3.51B | 505.20M | 16.79% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |
| Shree Ganesh Remedies | 1.06B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |